Trial to start for Jeannette man accused of selling drugs used in brother’s fatal overdose |

Trial to start for Jeannette man accused of selling drugs used in brother’s fatal overdose

Rich Cholodofsky

Opening statements will begin Tuesday in the murder trial of a Jeannette man accused of selling drugs his brother used to fatally overdose three days after Christmas 2016.

Markus McGowan, 31, is charged with one felony count of drug delivery resulting in death. Police contend he sold $60 of fentanyl to his 22-year-old brother, Matthew McGowan, who died a day later in his Greensburg apartment.

Westmoreland County prosecutors said police found an unresponsive Matthew McGowan when they responded to a call Dec. 28, 2016, at his Eastmont Street apartment. A roommate, who had that day overdosed after consuming the drugs and was taken to a Greensburg hospital, implicated Markus McGowan as the man who sold him bags of what was believed to be heroin, court records say.

The roommate told police she returned home from the hospital that evening and found Matthew McGowan unconscious.

According to court records, Markus McGowan admitted to police he sold his brother six bags of the drug and gave him a seventh free. The lone count against Markus McGowan carries a maximum sentence of 40 years in prison for a conviction. He has been free on $250,000 bond.

On Monday, 12 jurors and two alternates were selected for the trial before Common Pleas Judge Christopher Feliciani.

Last week, Feliciani ordered police take into custody a key witness prosecutors said they need to testify but who had not committed to appearing in court. That witness was released Friday after she was outfitted with a court-ordered monitoring device usually used in the county probation department’s house arrest program.

Rich Cholodofsky is a Tribune-Review staff writer. You can contact Rich at 724-830-6293, [email protected] or via Twitter .

Categories: Local | Westmoreland
TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.